对于增强重组蛋白质生产的大肠杆菌分泌系统的进展
Sudarsana Reddy Lokireddy1,2, Sridhar Rao Kunchala3, Ramakrishna Vadde4
1Oncosmis Biotech Private Limited, Plot No 3, Genpact Rd, IDA Uppal, Hyderabad, TG, 500 007, India.
World journal of microbiology & biotechnology
|March 2, 2025
概括
大肠杆菌可以被改造为增强蛋白质分泌,克服包括体等自然限制. 本综述详细介绍了改善E. coli重组蛋白产量和细胞外分泌量的策略和技术.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 分子生物学分子生物学
背景情况:
- 大肠杆菌是重组蛋白质生产的关键宿主,因为它的快速生长和遗传可处理性.
- 一个主要的限制是低效的天然蛋白质分泌,导致细胞质聚合和降低产量.
- 增强细胞外分泌对于提高重组蛋白质生产的整体效率至关重要.
研究的目的:
- 审查大肠杆菌中天然和人工蛋白质分泌系统.
- 为突出基因工程和合成生物学在改善蛋白质分泌方面的进步.
- 讨论新兴技术和克服分泌挑战的策略.
主要方法:
- 探索自然分泌途径 (I,III,Sec,Tat类型) 的研究.
- 对基因工程,突变发生和合成生物学方法的审查.
- 对ESETEC®和BacSec®等新兴平台的分析.
- 讨论减轻蛋白质聚合和增强折叠的策略.
主要成果:
- 不同的自然和人工系统为大肠杆菌中增强蛋白质分泌提供了潜在的潜力.
- 基因工程和合成生物学已经在蛋白质产量和分泌效率方面取得了显著的改进.
- 新兴技术显示出可扩展和具有成本效益的蛋白质生产的前景.
- 创新策略有效地应对诸如蛋白质聚合等挑战.
结论:
- 大肠杆菌具有可适应的自然和工程系统,用于增强蛋白质分泌.
- 生物技术的进步为高效的重组蛋白质生产提供了有希望的解决方案.
- 克服大肠杆菌的分泌限制对于工业应用和未来的蛋白质技术至关重要.
相关概念视频
Bacterial Translocation and Protein Secretion
Bacterial protein secretion involves translocation systems to ensure proteins reach their designated locations, including the plasma membrane, periplasm, outer membrane, or the external environment. These translocation systems are vital for bacterial physiology, supporting processes like membrane assembly, enzymatic activity in the periplasm, and interactions with the external environment. The division of labor between Sec and Tat pathways ensures efficiency in handling proteins with diverse...
Gram-negative Bacterial Protein Secretion Systems
Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


